Transepithelial Transport of Drugs by the Multidrug Transporter in Cultured Madin-Darby Canine Kidney Cell Epithelia
Overview
Affiliations
We studied transepithelial transport of 3H-labeled hydrophobic cationic drugs in epithelia formed by wild-type and by drug-resistant Madin-Darby canine kidney (MDCk) cells that had been infected with a retrovirus carrying the multidrug-resistance (MDR1) cDNA which encodes the P-glycoprotein. P-glycoprotein is an ATP consuming plasma membrane multidrug transporter responsible for the efflux of cytotoxic chemotherapeutic drugs from resistant cancer cells. Wild-type MDCK cells have small amounts of P-glycoprotein detected by immunoprecipitation. Net transepithelial transport across wild-type MDCK epithelia was demonstrated. Basal to apical flux of 100 nM vinblastine was about six times higher than apical to basal flux. Addition of unlabeled vinblastine reduced basal to apical flux of tracer and increased apical to basal flux of tracer, a pattern expected if there is a saturable pump that extrudes vinblastine at the apical plasma membrane. Daunomycin, vincristine, and actinomycin D were also actively transported and at 20 microM these agents inhibited transport of vinblastine, suggesting that wild-type MDCK cells have a common transporter for all these drugs. Vinblastine transport was also inhibited by 20 microM verapamil, which inhibits the multidrug transporter and reverses multidrug-resistance in non-polarized cells. Net transepithelial transport of all these cytotoxic drugs and of verapamil was much higher in epithelia formed by MDCK cells infected with a human MDR1 virus (MDR-MDCK) which is expressed on the apical surface of MDR-MDCK monolayers. Because the transport of these cytotoxic drugs and verapamil is increased in MDR-MDCK epithelia compared to wild-type MDCK epithelia, transport in both these cell populations can be attributed to P-glycoprotein. These results are consistent with a role for P-glycoprotein in multidrug secretory transport across the epithelium of the proximal tubule since P-glycoprotein is normally expressed on the apical membrane of proximal tubule cells.
A novel molecular class that recruits HDAC/MECP2 complexes to PU.1 motifs reduces neuroinflammation.
Ralvenius W, Mungenast A, Woolf H, Huston M, Gillingham T, Godin S J Exp Med. 2023; 220(11).
PMID: 37642942 PMC: 10465325. DOI: 10.1084/jem.20222105.
Prediction of Drug Clearance from Enzyme and Transporter Kinetics.
Kulkarni P, Youssef A, Argikar A Methods Mol Biol. 2021; 2342:369-417.
PMID: 34272702 DOI: 10.1007/978-1-0716-1554-6_14.
Pharmacological validation of TDO as a target for Parkinson's disease.
Perez-Pardo P, Grobben Y, Willemsen-Seegers N, Hartog M, Tutone M, Muller M FEBS J. 2021; 288(14):4311-4331.
PMID: 33471408 PMC: 8359396. DOI: 10.1111/febs.15721.
P-Glycoprotein: One Mechanism, Many Tasks and the Consequences for Pharmacotherapy of Cancers.
Seelig A Front Oncol. 2020; 10:576559.
PMID: 33194688 PMC: 7649427. DOI: 10.3389/fonc.2020.576559.
Role for Drug Transporters in Chemotherapy-Induced Peripheral Neuropathy.
Stage T, Hu S, Sparreboom A, Kroetz D Clin Transl Sci. 2020; 14(2):460-467.
PMID: 33142018 PMC: 7993259. DOI: 10.1111/cts.12915.